Cytosar

In the US, Cytosar (cytarabine systemic) is a member of the drug class antimetabolites and is used to treat Acute Myeloid Leukemia, Acute Nonlymphocytic Leukemia, Chronic Myelogenous Leukemia, Leukemia, Meningeal Leukemia and Non-Hodgkin's Lymphoma.

US matches:

• Cytosar-U

Ingredient matches for Cytosar

Cytarabine

Cytarabine is reported as an ingredient of Cytosar in the following countries:

• Bahrain


• Belgium


• Bulgaria


• Canada


• China


• Colombia


• Croatia (Hrvatska)


• Czech Republic


• Estonia


• Georgia


• Ghana


• Hong Kong


• Hungary


• Israel


• Kenya


• Latvia


• Liberia


• Lithuania


• Luxembourg


• Oman


• Peru


• Poland


• Portugal


• Romania


• Russian Federation


• Serbia


• Sierra Leone


• Singapore


• Slovakia


• South Africa


• Switzerland


• Taiwan


• Tanzania


• Uganda


• Venezuela


• Vietnam


• Zimbabwe

International Drug Name Search